KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications - Raw experimental data pt. 1
收藏资源简介：
Raw experimental data for "KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications" accepted for publication in Haematologica (2026) - part 1. Detailed descirption of experimental procedures is available in Zenodo (https://doi.org/10.5281/zenodo.21492388). Flow cytometry results from GFP growth competition assay performed in JURKAT and RPMI-8402 T-ALL cell lines upon CRISPR inhibition-mediated repression of KSR2 gene. RT-qPCR evaluation of KSR2 expression in T-ALL cell lines upon CRISPR inhibition-mediated repression of KSR2 gene. Immunoblotting for evaluation of the level of total and activated (phospho-Thr172) AMPKα protein performed in T-ALL cell lines upon CRISPR inhibition-mediated repression of KSR2 gene.
